Are exon 19 deletions and L858R EGFR mutations in non-small-cell lung cancer clinically different?

Br J Cancer. 2007 Jan 29;96(2):399; author reply 400. doi: 10.1038/sj.bjc.6603564. Epub 2007 Jan 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / genetics*
  • Cohort Studies
  • ErbB Receptors / genetics*
  • Exons*
  • Gene Deletion*
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / genetics*
  • Mutation*

Substances

  • Antineoplastic Agents
  • ErbB Receptors